Document ID: chunk:federal_register_of_legislation:F2024L01521:clause:1_22
Version: federal_register_of_legislation:F2024L01521
Segment Type: clause
Provision Reference: sch 1 cl 22
Character Range: 11833–13279

22  Schedule 1 (table)
After:
Latanoprost with timolol  Eye drops 50 micrograms latanoprost with timolol 5 mg (as maleate) per mL, 2.5 mL  Application to the Eye  APO‑Latanoprost/Timolol 0.05/5  2.5 months stock by reference to usual demand

insert:
Leflunomide    Tablet 10 mg                                         Oral  APO-LEFLUNOMIDE    4 months stock by reference to usual demand of both Leflunomide APOTEX and APO-LEFLUNOMIDE added together
Leflunomide    Tablet 20 mg                                         Oral  APO-LEFLUNOMIDE    4 months stock by reference to usual demand of both Leflunomide APOTEX and APO-LEFLUNOMIDE added together
Lercanidipine  Tablet containing lercanidipine hydrochloride 10 mg  Oral  ARX-LERCANIDIPINE  6 months stock by reference to usual demand of both Lercanidipine APOTEX and ARX-LERCANIDIPINE added together
Lercanidipine  Tablet containing lercanidipine hydrochloride 20 mg  Oral  ARX-LERCANIDIPINE  6 months stock by reference to usual demand of both Lercanidipine APOTEX and ARX-LERCANIDIPINE added together
Letrozole      Tablet 2.5 mg                                        Oral  ARX-LETROZOLE      4 months stock by reference to usual demand of both Letrozole APOTEX and ARX-LETROZOLE added together
Letrozole      Tablet 2.5 mg                                        Oral  Letrozole APOTEX   4 months stock by reference to usual demand of both Letrozole APOTEX and ARX-LETROZOLE added together